{"Name":"SillaJen","perma":"sillajen","BasicInfo":{"funded":"2003-01-01","isClosed":false,"closed":null,"short":"Sillajen, a Seoul, South Korea-based global oncolytic immunotherapeutic company."},"FundingRounds":[{"funding_type":"venture","series":null,"announcedDate":"2016-03-21","moneyRaised":12000000}],"Acquisitions":[],"AcquiredBy":null,"IPO":null,"Investments":[],"Products":[],"ProductsPermas":[],"CurrentTeam":[{"title":"Chief Executive Officer","started":null,"ended":null,"firstName":"Eun-Sang","lastName":"Moon"},{"title":"COO","started":null,"ended":null,"firstName":"Sung-Kuon","lastName":"Chi"},{"title":"CTO","started":null,"ended":null,"firstName":"Georg","lastName":"Roth"},{"title":"CFO","started":null,"ended":null,"firstName":"Sung-Jin","lastName":"Yoon"}],"PastTeam":[]}
